Nutra Pharma Corp (NPHC)

[k9narc]

https://www.sec.gov/litigation/litreleases/2018/lr24295.htm


SEC Charges Florida Microcap Company, CEO and Consultant with Fraud

Litigation Release No. 24295 / September 28, 2018

Securities and Exchange Commission v. Nutra Pharma Corp. et al, No. 1:18-cv-05459 (E.D.N.Y filed September 28, 2018)

The Securities and Exchange Commission today charged a Florida-based microcap issuer, its CEO, and one of its consultants with making material misstatements to retail investors, among other charges.

According to the SEC's complaint, Nutra Pharma Corp., a microcap issuer that purports to make pain relief drugs with cobra venom, and its CEO, Rik Deitsch, issued or posted six press releases that materially misled investors.